Previous 10 | Next 10 |
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 26, 2022) - Neovasc , Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced the United States Food and Drug Administration ("FDA") has approved a protocol supplement to the COSIRA-II Investig...
Neovasc ( NASDAQ: NVCN ) has expanded its direct sales operations in Europe to include the United Kingdom, effective July 1, 2022 . The company has hired its first two direct employees in England and plans future growth in the sales team as the commercial requirements incr...
Expansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer(TM) Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 5, 2022) - Neovasc , Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced tha...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - June 08, 2022 - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small Cap Virtual Investor C...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - May 23, 2022 - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright Global Investment Conference to be held May 23-26, 2...
Neovasc (NASDAQ:NVCN) has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule for continued listing on the Nasdaq. For further details see: Neovasc regains compliance with Nasdaq minimum bid price rule
Neovasc Inc. (NVCN) Q1 2022 Earnings Conference Call May 12, 2022 16:30 ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President and Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants Vernon Bernardino - H.C. Wainwright Present...
Neovasc press release (NASDAQ:NVCN): Q1 GAAP EPS of -$3.75 misses by $2.50. Revenue of $0.61M (+35.6% Y/Y) misses by $0.19M. “The first quarter of 2022 was another record setting first quarter in revenue, with continued progress towards our value-creation strategies, in particular on r...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 12, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today reported financial results for the quarter ended March 31, 2022. Recent Highlights Achieved Q1 revenue of approximately $611...
AAIC, ACB, ACHV, AFRM, AGRO, AGRX, APDN, APTX, AQN, AVPT, AXU, BANX, BBI, BEAT, BIOL, BLBD, BLND, BOXL, BSQR, CBAY, CDXC, CLLS, CLVR, CODX, COMP, CORZ, CRMD, CTIC, CURI, CWCO, DARE, DUOL, EDR, ETON, EYEN, FIGS, GPL, GWH, HLI, HTGM, IBIO, IDN, OTCQB:IGXT, IMMR, INDI, INTZ, INUV, JOBY, KMPH, LC...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...